Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz-Josef Neumann

Showing results (361-370 of 477) with videos related to

Pageof 48
Sort By:
The New England Journal of Medicine|August 28, 2012
Intraaortic balloon support for myocardial infarction with cardiogenic shockHolger Thiele, Uwe Zeymer, Franz-Josef Neumann, et al.
JACC. Cardiovascular Interventions|April 23, 2016
Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter StudyGidon Y Perlman, Philipp Blanke, Danny Dvir, et al.
American Heart Journal|October 8, 2020
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stentMarco Valgimigli, Davide Cao, Rajendra R Makkar, et al.
Lancet (London, England)|August 6, 2017
Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trialsAlexander Jobs, Shamir R Mehta, Gilles Montalescot, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 23, 2015
ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysisMartin Orban, Tobias Limbourg, Franz-Josef Neumann, et al.
Journal of the American Heart Association|November 15, 2021
Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary SyndromesGjin Ndrepepa, Franz-Josef Neumann, Maurizio Menichelli, et al.
Circulation. Cardiovascular Interventions|January 31, 2015
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trialStephan Windecker, Michael Haude, Franz-Josef Neumann, et al.
European Heart Journal|June 19, 2018
Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trialDirk Sibbing, Lisa Gross, Dietmar Trenk, et al.
Journal of Cardiovascular Translational Research|May 27, 2025
Randomised Comparison of Culotte- versus Double Kissing Crush Stenting in de novo non-left Main Coronary Bifurcation Lesions: Rationale and Design of the Bifurcation Bad Krozingen trial-3 (BBK-3)Faridun Rahimi, Nikolaus Löffelhardt, Jan Minners, et al.
Journal of Thrombosis and Thrombolysis|February 7, 2012
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trialSean van Diepen, Matthew T Roe, Renato D Lopes, et al.
Pageof 48

Showing results (361-370 of 477) with videos related to

Sort By:
Pageof 48
The New England Journal of Medicine|August 28, 2012
Intraaortic balloon support for myocardial infarction with cardiogenic shockHolger Thiele, Uwe Zeymer, Franz-Josef Neumann, et al.
JACC. Cardiovascular Interventions|April 23, 2016
Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter StudyGidon Y Perlman, Philipp Blanke, Danny Dvir, et al.
American Heart Journal|October 8, 2020
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stentMarco Valgimigli, Davide Cao, Rajendra R Makkar, et al.
Lancet (London, England)|August 6, 2017
Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trialsAlexander Jobs, Shamir R Mehta, Gilles Montalescot, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 23, 2015
ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysisMartin Orban, Tobias Limbourg, Franz-Josef Neumann, et al.
Journal of the American Heart Association|November 15, 2021
Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary SyndromesGjin Ndrepepa, Franz-Josef Neumann, Maurizio Menichelli, et al.
Circulation. Cardiovascular Interventions|January 31, 2015
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trialStephan Windecker, Michael Haude, Franz-Josef Neumann, et al.
European Heart Journal|June 19, 2018
Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trialDirk Sibbing, Lisa Gross, Dietmar Trenk, et al.
Journal of Cardiovascular Translational Research|May 27, 2025
Randomised Comparison of Culotte- versus Double Kissing Crush Stenting in de novo non-left Main Coronary Bifurcation Lesions: Rationale and Design of the Bifurcation Bad Krozingen trial-3 (BBK-3)Faridun Rahimi, Nikolaus Löffelhardt, Jan Minners, et al.
Journal of Thrombosis and Thrombolysis|February 7, 2012
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trialSean van Diepen, Matthew T Roe, Renato D Lopes, et al.
Pageof 48